Browsing by Subject "Docking studies"
Now showing items 1-1 of 1
-
(MDPI, 2021)The Smoothened (SMO) receptor is the most druggable target in the Hedgehog (HH) pathway for anticancer compounds. However, SMO antagonists such as vismodegib rapidly develop drug resistance. In this study, new SMO antagonists ...